9,209
Views
27
CrossRef citations to date
0
Altmetric
Review Articles

Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion

ORCID Icon, &
Pages 128-140 | Received 14 Dec 2018, Accepted 25 Feb 2019, Published online: 26 Apr 2019

References

  • He W, Goodkind D, Kowal P. An aging world: 2015. US Census Bureau International Population Reports [Internet] 2016; [cited 2017 Sep 21]; P95/16-1. Available from: https://www.census.gov/content/dam/Census/library/publications/2016/demo/p95-16-1.pdf.
  • Centers for Disease Control and Prevention. Ten great public health achievements – United States, 1900–1999. MMWR Morb Mortal Wkly Rep. 1999;48:241–243.
  • Centers for Disease Control and Prevention. ACIP vaccine recommendations and guidelines [Internet]. 2013. Atlanta, GA, United States: Centers for Disease Control and Prevention. [updated 2018 Jan 26; cited 2018 Sep 21]. Available from: https://www.cdc.gov/vaccines/hcp/acip-recs/index.html.
  • Zhang G, Samuel JE. Vaccines against Coxiella infection. Expert Rev Vaccines. 2004;3:577–584.
  • World Health Organization. Vaccines and diseases [Internet]. 2018. Geneva, Switzerland: World Health Organization. [cited 2018 Sep 21]. Available from: https://www.who.int/immunization/diseases/en/.
  • Thomas-Crusells J, McElhaney JE, Aguado MT. Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization. Vaccine. 2012;30:6007–6012.
  • Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis. 2002;2:659–666.
  • Sheikh S, Biundo E, Courcier S, et al. A report on the status of vaccination in Europe. Vaccine. 2018;36:4979–4992.
  • Immunization Action Coalition. Vaccinating adults: a step-by-step guide. IAC Guide [Internet]. 2017. Saint Paul, MN. [cited 2018 Sep 21]. Available from: http://www.immunize.org/guide/pdfs/vacc-adults-entire.pdf.
  • Esposito S, Franco E, Gavazzi G, et al. The public health value of vaccination for seniors in Europe. Vaccine. 2018;36:2523–2528.
  • Bonanni P, Bonaccorsi G, Lorini C, et al. Focusing on the implementation of 21st century vaccines for adults. Vaccine. 2018;36:5358–5365.
  • Aguado MT, Barratt J, Beard JR, et al. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017. Vaccine. 2018;36:921–931.
  • Michel JP, Gusmano M, Blank PR, et al. Vaccination and healthy ageing: how to make life-course vaccination a successful public health strategy. Eur Geriatr Med. 2010;1:155–165.
  • Srivastav A, Black CL, Lutz CS, et al. U.S. clinicians' and pharmacists' reported barriers to implementation of the standards for adult immunization practice. Vaccine. 2018;36:6772–6781.
  • Whitaker JA, von Itzstein MS, Poland GA. Strategies to maximize influenza vaccine impact in older adults. Vaccine. 2018;36:5940–5948.
  • Smith LE, Webster RK, Weinman J, et al. Psychological factors associated with uptake of the childhood influenza vaccine and perception of post-vaccination side-effects: a cross-sectional survey in England. Vaccine. 2017;35:1936–1945.
  • Telford R, Rogers A. What influences elderly peoples' decisions about whether to accept the influenza vaccination? A qualitative study. Health Educ Res. 2003;18:743–753.
  • Beard JR, Officer A, de Carvalho IA, et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387:2145–2154.
  • Kline KA, Bowdish DM. Infection in an aging population. Curr Opin Microbiol. 2016;29:63–67.
  • US National Institutes of Aging, World Health Organization. Global Health and Aging. WHO Report [Internet] 2011; [cited 2018 Sep 21]. Available from: http://www.who.int/ageing/publications/global_health.pdf.
  • Sadighi Akha AA. Aging and the immune system: an overview. J Immunol Methods. 2018;463:21–26.
  • Clements SJ, R. Carding S. Diet, the intestinal microbiota, and immune health in aging. Crit Rev Food Sci Nutr. 2018;58:651–661.
  • Gautret P, Gaudart J, Leder K, et al. Travel-associated illness in older adults (>60 y). J Travel Med. 2012;19:169–177.
  • Harvey K, Esposito DH, Han P, et al. Surveillance for travel-related disease – GeoSentinel Surveillance System, United States, 1997–2011. MMWR Surveill Summ. 2013;62:1–23.
  • Ozawa S, Portnoy A, Getaneh H, et al. Modeling the economic burden of adult vaccine-preventable diseases in the United States. Health Aff (Millwood). 2016;35:2124–2132.
  • Poland GA, Jacobson RM, Ovsyannikova IG. Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine. 2009;27:3240–3244.
  • Wicker S, Maltezou HC. Vaccine-preventable diseases in Europe: where do we stand? Expert Rev Vaccines. 2014;13:979–987.
  • Supporting Active Ageing Through Immunisation Partnership. Adult vaccination: a key component of healthy ageing – The benefits of life-course immunisation in Europe. SAATI Report [Internet] 2013; [cited 2018 Sep 21]. Available from: https://www.ifa-fiv.org/wp-content/uploads/2015/09/SAATI-Report-2013.pdf.
  • Williams WW, Lu P-J, O’Halloran A, et al. Surveillance of vaccination coverage among adult populations – United States, 2015. MMWR Surveill Summ. 2017;66:1–28.
  • European Centre for Disease Prevention and Control. Seasonal influenza vaccination in Europe – Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007–2008 to 2014–2015. ECDC Technical Report [Internet] 2017; [cited 2018 Sep 21]. Available from: https://ecdc.europa.eu/sites/portal/files/documents/influenza-vaccination-2007%E2%80%932008-to-2014%E2%80%932015.pdf.
  • van Wijhe M, McDonald SA, de Melker HE, et al. Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis. Lancet Infect Dis. 2016;16:592–598.
  • Bonanni P. Demographic impact of vaccination: a review. Vaccine. 1999;17:S120–S125.
  • Locarnini S, Hatzakis A, Chen D-S, et al. Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs. J Hepatol. 2015;62:S76–S86.
  • Owusu-Darko S, Diouf K, Nour NM. Elimination of maternal and neonatal tetanus: a 21st-century challenge. Rev Obstet Gynecol. 2012;5:e151–e157.
  • Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis. 2011;43:683–689.
  • Rashid H, Khandaker G, Booy R. Vaccination and herd immunity: what more do we know? Curr Opin Infect Dis. 2012;25:243–249.
  • Mina MJ, Metcalf CJ, de Swart RL, et al. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015;348:694–699.
  • Miller EC, Elkind MS. Infection and stroke: an update on recent progress. Curr Neurol Neurosci Rep. 2016;16:29.
  • Madjid M, Aboshady I, Awan I, et al. Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J. 2004;31:4–13.
  • Zhang Y, Luo G, Huang Y, et al. Risk of stroke/transient ischemic attack or myocardial infarction with herpes zoster: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2017;26:1807–1816.
  • Warren-Gash C. Herpes zoster: epidemiological links with stroke and myocardial infarction. J Infect Dis. 2018;218:S102–S106.
  • Boehme AK, Luna J, Kulick ER, et al. Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol. 2018;5:456–463.
  • Fang YA, Chen CI, Liu JC, et al. Influenza vaccination reduces hospitalization for heart failure in elderly patients with chronic kidney disease: a population-based cohort study. Acta Cardiol Sin. 2016;32:290–298.
  • Sung LC, Chen CI, Fang YA, et al. Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: a population-based cohort study. Vaccine. 2014;32:3843–3849.
  • Lee KR, Bae JH, Hwang IC, et al. Effect of influenza vaccination on risk of stroke: a systematic review and meta-analysis. Neuroepidemiology. 2017;48:103–110.
  • Siriwardena AN, Gwini SM, Coupland CA. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case–control study. CMAJ. 2010;182:1617–1623.
  • Hung IF, Leung AY, Chu DW, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis. 2010;51:1007–1016.
  • Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2016–17 Influenza Season [Internet]. 2017. Atlanta, GA, United States: Centers for Disease Control and Prevention. [updated 2017 Sep 28; cited 2018 Sep 21]. Available from: https://www.cdc.gov/flu/fluvaxview/coverage-1617estimates.htm#data.
  • Public Health England. Seasonal influenza vaccine uptake in children of primary school age: winter season 2017 to 2018. Research and Analysis [Internet] 2018; London, UK: Public Health England. [cited 2018 Sep 21]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/710482/Seasonal_influenza_vaccine_uptake_in_children_of_primary_school_age_winter_season_2017_to_2018.pdf.
  • Public Health England. Seasonal influenza vaccine uptake in GP patients: winter season 2017 to 2018. Official Statistics [Internet] 2018; London, UK: Public Health England. [cited 2018 Sep 21]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/710416/Seasonal_influenza_vaccine_uptake_in_GP_patients_winter_season_2017_to_2018.pdf.
  • Ramanadhan S, Galarce E, Xuan Z, et al. Addressing the vaccine hesitancy continuum: an audience segmentation analysis of American adults who did not receive the 2009 H1N1 vaccine. Vaccines. 2015;3:556–578.
  • World Health Organization. Constitution of the World Health Organization [Internet]. New York, NY, USA: World Health Organization; 1946. [cited 1018 Sep 21]. Available from: http://www.who.int/about/mission/en/.
  • World Health Organization. World report on ageing and health. WHO Report [Internet] 2015; [cited 2018 Sep 21]. Available from: http://apps.who.int/iris/bitstream/handle/10665/186463/9789240694811_eng.pdf;jsessionid=A1523802F2AC6CFF6DD06F16C5EA7E13?sequence=1.
  • Finch CE, Crimmins EM. Inflammatory exposure and historical changes in human life-spans. Science. 2004;305:1736–1739.
  • Bengtsson T, Brostrom G. Do conditions in early life affect old-age mortality directly and indirectly? Evidence from 19th-century rural Sweden. Soc Sci Med. 2009;68:1583–1590.
  • Franceschi C, Garagnani P, Parini P, et al. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576–590.
  • Bektas A, Schurman SH, Sen R, et al. Aging, inflammation and the environment. Exp Gerontol. 2018;105:10–18.
  • Kennedy BK, Berger SL, Brunet A, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159:709–713.
  • Kohanski RA, Deeks SG, Gravekamp C, et al. Reverse geroscience: how does exposure to early diseases accelerate the age-related decline in health? Ann NY Acad Sci. 2016;1386:30–44.
  • Franceschi C, Garagnani P, Morsiani C, et al. The continuum of aging and age-related diseases: common mechanisms but different rates. Front Med. 2018;5:61.
  • Ehninger D, Neff F, Xie K. Longevity, aging and rapamycin. Cell Mol Life Sci. 2014;71:4325–4346.
  • Blagosklonny MV. Rapamycin extends life- and health span because it slows aging. Aging. 2013;5:592–598.
  • Wei W, Ji S. Cellular senescence: molecular mechanisms and pathogenicity. J Cell Physiol. 2018;233:9121–9135.
  • Brancati FL, Chow JW, Wagener MM, et al. Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet. 1993;342:30–33.
  • Adamuz J, Viasus D, Jimenez-Martinez E, et al. Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia. J Infect. 2014;68:534–541.
  • Laporte L, Hermetet C, Jouan Y, et al. Ten-year trends in intensive care admissions for respiratory infections in the elderly. Ann Intensive Care. 2018;8:84.
  • Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67:71–79.
  • Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48:1–28.
  • Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59:1–62.
  • Ethgen O, Baron-Papillon F, Cornier M. How much money is spent on vaccines across Western European countries? Hum Vaccin Immunother. 2016;12:2038–2045.
  • European Commission. Growing the European silver economy. European Commission Background Paper [Internet] 2015; [cited 2018 Sep 21]. Available from: http://ec.europa.eu/research/innovation-union/pdf/active-healthy-ageing/silvereco.pdf.
  • Mensah GA, Wei GS, Sorlie PD, et al. Decline in cardiovascular mortality: possible causes and implications. Circ Res. 2017;120:366–380.
  • Lackland DT, Roccella EJ, Deutsch AF, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014;45:315–353.
  • Ford ES, Bergmann MM, Boeing H, et al. Healthy lifestyle behaviors and all-cause mortality among adults in the United States. Prev Med. 2012;55:23–27.
  • Behrens G, Fischer B, Kohler S, et al. Healthy lifestyle behaviors and decreased risk of mortality in a large prospective study of U.S. women and men. Eur J Epidemiol. 2013;28:361–372.
  • Safaeian M, Solomon D, Castle PE. Cervical cancer prevention – cervical screening: science in evolution. Obstet Gynecol Clin North Am. 2007;34:739–760.
  • Steverink N, Lindenberg S, Slaets J. How to understand and improve older people’s self-management of wellbeing. Eur J Ageing. 2005;2:235–244.
  • Cramm JM, Twisk J, Nieboer A. Self-management abilities and frailty are important for healthy aging among community-dwelling older people; a cross-sectional study. BMC Geriatr. 2014;14:28.
  • Tanimura C, Matsumoto H, Tokushima Y, et al. Self-care agency, lifestyle, and physical condition predict future frailty in community-dwelling older people. Nurs Health Sci. 2018;20:31–38.
  • Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. Lancet. 2010;376:1261–1271.
  • An R, Ji M, Zhang S. Effectiveness of social media-based interventions on weight-related behaviors and body weight status: review and meta-analysis. Am J Health Behav. 2017;41:670–682.
  • Bala MM, Strzeszynski L, Topor-Madry R. Mass media interventions for smoking cessation in adults. Cochrane Database Syst Rev. 2017;11:Cd004704.
  • Wolfenden L, Nathan NK, Sutherland R, et al. Strategies for enhancing the implementation of school-based policies or practices targeting risk factors for chronic disease. Cochrane Database Syst Rev. 2017;11:CD011677.
  • Lytras T, Kopsachilis F, Mouratidou E, et al. Interventions to increase seasonal influenza vaccine coverage in healthcare workers: a systematic review and meta-regression analysis. Hum Vaccin Immunother. 2016;12:671–681.
  • Frazer K, Callinan JE, McHugh J, et al. Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev. 2016;2:Cd005992.
  • Abreu D, Sousa P, Matias-Dias C, et al. Longitudinal impact of the smoking ban legislation in acute coronary syndrome admissions. Biomed Res Int. 2017;2017:1.
  • Levy DT, Huang AT, Havumaki JS, et al. The role of public policies in reducing smoking prevalence: results from the Michigan SimSmoke tobacco policy simulation model. Cancer Causes Control. 2016;27:615–625.
  • Elder RW, Shults RA, Sleet DA, et al. Effectiveness of mass media campaigns for reducing drinking and driving and alcohol-involved crashes: a systematic review. Am J Prev Med. 2004;27:57–65.
  • Walkinshaw E. Mandatory vaccinations: the international landscape. CMAJ. 2011;183:E1167–E1168.
  • Bozzola E, Spina G, Russo R, et al. Mandatory vaccinations in European countries, undocumented information, false news and the impact on vaccination uptake: the position of the Italian pediatric society. Ital J Pediatr. 2018;44:67.
  • Haire B, Komesaroff P, Leontini R, et al. Raising rates of childhood vaccination: the trade-off between coercion and trust. Bioethical Inquiry. 2018;15:199–209.
  • Galanakis E, D’Ancona F, Jansen A, et al. The issue of mandatory vaccination for healthcare workers in Europe. Expert Rev Vaccines. 2014;13:277–283.
  • Schwartz JL. Evidence and ethics in mandatory vaccination policies. Am J Bioeth. 2013;13:46–48.
  • Yang YT, Silverman RD. Mandatory influenza vaccination and religious accommodation for healthcare workers: lessons from recent legal challenges. Vaccine. 2018;36:3998–4000.
  • Hakim H, Gaur AH, McCullers JA. Motivating factors for high rates of influenza vaccination among healthcare workers. Vaccine. 2011;29:5963–5969.
  • French DP, Cameron E, Benton JS, et al. Can communicating personalised disease risk promote healthy behaviour change? A systematic review of systematic reviews. Ann Behav Med. 2017;51:718–729.
  • Randolph W, Viswanath K. Lessons learned from public health mass media campaigns: marketing health in a crowded media world. Annu Rev Public Health. 2004;25:419–437.
  • McDermott MS, Oliver M, Iverson D, et al. Effective techniques for changing physical activity and healthy eating intentions and behaviour: a systematic review and meta-analysis. Br J Health Psychol. 2016;21:827–841.
  • Jacobson Vann JC, Jacobson RM, Coyne-Beasley T, et al. Patient reminder and recall interventions to improve immunization rates. Cochrane Database Syst Rev. 2018;1:Cd003941.
  • Thomas RE, Lorenzetti DL. Interventions to increase influenza vaccination rates of those 60 years and older in the community. Cochrane Database Syst Rev. 2018;5:Cd005188.
  • Eilers R, Krabbe PFM, de Melker HE. Motives of Dutch persons aged 50 years and older to accept vaccination: a qualitative study. BMC Public Health. 2015;15:493.
  • Forster AS, Rockliffe L, Chorley AJ, et al. A qualitative systematic review of factors influencing parents' vaccination decision-making in the United Kingdom. SSM Popul Health. 2016;2:603–612.
  • Carolan K, Verran J, Crossley M, et al. Impact of educational interventions on adolescent attitudes and knowledge regarding vaccination: a pilot study. PLoS One. 2018;13:e0190984.
  • Nyhan B, Reifler J, Richey S, et al. Effective messages in vaccine promotion: a randomized trial. Pediatrics. 2014;133:e835–e842.
  • Parsons JE, Newby KV, French DP. Do interventions containing risk messages increase risk appraisal and the subsequent vaccination intentions and uptake? – a systematic review and meta-analysis. Br J Health Psychol. 2018;23:1084–1106.
  • Vietri JT, Li M, Galvani AP, et al. Vaccinating to help ourselves and others. Med Decis Making. 2012;32:447–458.
  • Shim E, Chapman GB, Townsend JP, et al. The influence of altruism on influenza vaccination decisions. J R Soc Interface. 2012;9:2234–2243.
  • Hendrix KS, Finnell SME, Zimet GD, et al. Vaccine message framing and parents' intent to immunize their infants for MMR. Pediatrics. 2014;134:e675.
  • Tran BX, Boggiano VL, Nguyen LH, et al. Media representation of vaccine side effects and its impact on utilization of vaccination services in Vietnam. Ppa. 2018;12:1717–1728.
  • Yu W, Liu D, Zheng J, et al. Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China. Int J Epidemiol. 2016;45:441–449.
  • Capanna A, Gervasi G, Ciabattini M, et al. Effect of mass media on influenza vaccine coverage in the season 2014/2015: a regional survey in Lazio, Italy. J Prev Med Hyg. 2015;56:E72–E76.
  • Morin A, Lemaitre T, Farrands A, et al. Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: which key messages in light of a new immunization program? Vaccine. 2012;30:5921–5927.
  • Korn L, Betsch C, Bohm R, et al. Social nudging: the effect of social feedback interventions on vaccine uptake. Health Psychol. 2018;37:1045–1054.
  • Nan X, Xie B, Madden K. Acceptability of the H1N1 vaccine among older adults: the interplay of message framing and perceived vaccine safety and efficacy. Health Commun. 2012;27:559–568.
  • Centers for Disease Control and Prevention. Chart of Vaccines in Delay or Shortage [Internet]. Atlanta, GA, United States: Centers for Disease Control and Prevention. 2018. [updated 2018 Jul 5; cited 2018 Sep 21]. Available from: https://www.cdc.gov/vaccines/hcp/clinical-resources/shortages.html#note4.
  • Dooling KL, Guo A, Patel M, et al. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018;67:103–108.
  • Frieden TR. Six components necessary for effective public health program implementation. Am J Public Health. 2014;104:17–22.
  • Esposito S, Durando P, Bosis S, et al. Vaccine-preventable diseases: from paediatric to adult targets. Eur J Intern Med. 2014;25:203–212.